Who owns ITEOS THERAPEUTICS INC?
- CUSIP Number: 46565g104
Tip: Access positions for across all investors
Analyze quarterly positions in Iteos Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Iteos Therapeutics stock
Who bought or sold ITEOS THERAPEUTICS INC this quarter?
There are no current stakeholders of Iteos Therapeutics.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Iteos Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2025 | 820k | $8.2M |
| Citadel Advisors | Jun 2025 | 413k | $4.1M |
| AQR Capital Management | Jun 2025 | 238k | $2.4M |
| Royal Bank of Canada | Jun 2025 | 186k | $1.4M |
| Wellington Management Company | Jun 2025 | 155k | $1.5M |
| Algert Coldiron Investors | Jun 2025 | 75k | $743k |
| Hsbc Holdings | Jun 2025 | 69k | $686k |
| D. E. Shaw & Co | Jun 2025 | 53k | $533k |
| FMR | Jun 2025 | 53k | $526k |
| Alliancebernstein | Jun 2025 | 44k | $441k |
| Springbok Capital Management | Jun 2025 | 39k | $392k |
| Two Sigma Advisers | Jun 2025 | 18k | $180k |
| Tudor Investment Corporation | Jun 2025 | 15k | $154k |
| Virtus Investment Advisers | Jun 2025 | 9.4k | $94k |
| IFP Advisors | Sep 2025 | 232.00 | $2.4k |